Event

4

February 2020

The Fight For Our Lives: Perspectives on the New Federal Price Controls for Medicines

11:30am-1:30pm | Fairmont Château Laurier - 1 Rideau Street, Ottawa

A proposed National Pharmacare Plan promises to eliminate gaps in Canadians’ coverage for prescription drugs. At the same time, sweeping changes to drug pricing regulations passed in the last days of the last parliament put into question Canadians’ access to new medicines. Is a single public plan built on lower drug prices and no new drugs the best solution to universal drug coverage?

The Economic Club of Canada is pleased to provide a platform for deliberating on viable alternatives that can meet the concerns of governments and citizens regarding the prices of medicines without sacrificing patient access.

Moderated by Tom Clark, Chair, Global Public Affairs and Former National News Anchor, the panel will discuss not only federal price controls and national pharmacare but also access to medicines for diseases, the proposed Canada Drug Agency and the challenges and opportunities inherent in inevitably high-priced “curative” therapies.

For millions of Canadians, we are literally in the “fight for our lives.”

February 4th is also timely for this conversation as we celebrate World Cancer Day, which is anchored on the theme of 'I Am and I Will,' an empowering call-to-action for personal commitment and the power of individuals affected by cancer.

- Lunch will be served -

Member price:
Individual seat: $89 +HST
Table (seats 10): $800 +HST

Regular price:
Individual seat: $110 +HST
Table (seats 10): $990 +HST

Important:
- For information about accessibility, please email natasha@economicclub.ca
- Dietary restriction notes and meal requests must be submitted to natasha@economicclub.ca by Wednesday, January 29, 2020.
- Refunds/credits: We require three business days notice in advance of the event date for ticket cancellations

*The views expressed on the Economic Club platform are not that of the Economic Club or its affiliates but of the speakers alone and the organizations they represent*

The Fight For Our Lives: Perspectives on the New Federal Price Controls for Medicines

Chris MacLeod

Founding Partner of Cambridge LLP
Founder and Chair of the Canadian Cystic Fibrosis Treatment Society

Chris MacLeod

Chris MacLeod is a founding Partner of Cambridge LLP. His practice focuses on complex business litigation including cross-border dispute resolution, multi-jurisdictional litigation, and private international law. He is the chair of the firm's Chinese Services Group.
Chris is a frequent speaker and writer on topics relevant to cross-border litigation, conflict of laws and private international law.

He has appeared before all levels of Court in the Province of Ontario, including the Ontario Court of Appeal. He has also appeared before the Supreme Court of Canada as co-counsel for an intervenor in Canada (Prime Minister) v. Khadr, 2010 SCC 3, [2010] 1 S.C.R. 44.

Chris is the Founder and Chair of the Canadian Cystic Fibrosis Treatment Society. As a Cystic Fibrosis patient himself, Chris brings decades of patient advocacy experience and is frequently asked for comment by the media on issues relating to access.

He estimates he spends a few hundred hours a year, pro bono, engaged in “boardroom advocacy, not courtroom advocacy.” He meets with insurance companies about coverage and advocates with pharmaceuticals to keep prices within range, develop compassionate care programs and cover the co-pay if possible.

Through the CF Treatment Society, he helps “any patient that is struggling with maneuvering in the system,” such as recourse available to them after a denial of drug coverage. MacLeod also engages in “more high-level, broad-based” advocacy for the development of more helpful policies.

Dr. Tania Stafinski, PhD

Co-founder and Director
Health Technology and Policy Unit in the School of Public Health at the University of Alberta

Dr. Tania Stafinski, PhD

Tania is Co-founder and Director of the Health Technology and Policy Unit in the School of Public Health at the University of Alberta. She is also Academic Advisor to the School’s Fellowship Program in Health System Improvement. Currently, she co-holds multi-year grants from Alberta Health in the areas of non-drug technology assessment and pharmaceutical decision-making processes.

With diverse training in both quantitative and qualitative methods, Tania’s research interests include the use of systems thinking to develop innovative ways of evaluating health services. Since 2011, she has been an Associate Editor of BMC Health Services Research.

Previously, Tania was a Research Associate at the Institute of Health Economics, where she was involved in the design and conduct of economic analyses and burden of illness studies. She was also responsible for establishing the Secretariat for the then newly created Health Technology Assessment International (HTAi). She remains involved in HTAi as a member of the steering committee of the Special Purpose Interest Group on Patient and Citizen Involvement.

Tania completed her PhD at the University of Alberta’s School of Public Health. She also completed a Master’s degree in Epidemiology from the University of Alberta. She received academic leadership awards while In both the Master’s and PhD programs, and was recognized by the Canadian Organization for Rare Disorders for her policy work to support timely, sustainable access to technologies for managing rare and ultra-rare conditions.

Dr. Yves Bolduc, MD

Physician
Past Quebec Health Minister and Special Advisor at Hill+Knowlton Strategies

Dr. Yves Bolduc, MD

Throughout his career as a doctor, manager, professor and politician, Dr. Bolduc has devoted himself to serving others. Holding a degree in medicine from Université Laval, Dr. Bolduc earned a graduate degree in bioethics from Université du Québec à Chicoutimi and a master’s degree in public administration from École nationale d’administration publique (ÉNAP). He has practiced medicine in a number of communities, most notably Abitibi-Témiscamingue and Saguenay-Lac-St-Jean, as well as in Ontario and as a Canadian civil aviation physician. He was also a professor of clinical medicine with the family medicine unit of the CSSS de Lac-Saint-Jean Est (Université de Sherbrooke) and an associate professor in the faculty of human sciences at Université du Québec à Chicoutimi.

Over the course of his career, he has most notably served as head of general medicine at the Centre Hospitalier Rouyn-Noranda, coroner, assistant professor in the faculty of family medicine at Université de Sherbrooke, associate professor in the faculty of human sciences at Université du Québec à Chicoutimi, and associate general practitioner at the Clinique de médecine générale d’Alma. Moreover, his contributions have been highlighted as a member of the Association des conseils des médecins, dentistes et pharmaciens du Québec, an organization for which he also served as president from 2002 to 2007.

In June of 2008, he was appointed Minister of Health and Social Services and remained in this position until September of 2012. He ended his political career as Minister of Education, Recreation and Sports as well as Minister of Higher Education, Research and Science earlier this year.

Durhane Wong-Rieger, PhD

President & CEO
Canadian Organization for Rare Disorders

Durhane Wong-Rieger, PhD

Durhane Wong-Rieger has served on numerous health policy advisory committees and panels and is a member of the Advisory Board for the Canadian Institutes of Health Research Institute of Genetics and the Patient Liaison Forum for the Canadian Drugs and Technologies in Health. Durhane is immediate Past-Chair of the International Alliance of Patient Organizations, and Board Member representing patient interests at DIA International Association. She has a PhD in psychology from McGill University.

Tom Clark

Chair, Global Public Affairs
Former National News Anchor

Tom Clark

Tom Clark joined Global after almost 45 years at the most senior levels of Canadian journalism. He left Global News on January 1, 2017, after serving as the network’s chief political correspondent and host of The West Block. He has interviewed every Canadian Prime Minister since Lester B. Pearson and has covered every federal election campaign since 1974. He has reported in eight active war zones and from over 33 countries. Tom was CTV’s China Bureau Chief and was also its Chief Washington Correspondent for five years. He has a deep understanding of Canada’s position in an increasingly complicated international dynamic. Tom is the recipient of Radio Television Digital News Association lifetime achievement award and has been named one of the most influential journalists in Ottawa.

Our Sponsors

Telus Interac Green Shield Canada